PLAU and combined immunodeficiency: The first kind of liver humanized mouse is the urokinase-type plasminogen activator/severe combined immunodeficiency (alb-uPA/Scid) mouse, in which overexpression of uPA transgene driven by the murine albumin (alb) promoter results in hypofibrinogenemia and severe hepatotoxicity (101).